The roles of pain facilitatory systems in opioid tolerance

Acta Anaesthesiologica Sinica

Volumn 38, Issue 3, 2000, Pages 155-166

  Hsu, M M ^a   Wong, C S ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Anti inflammatory agents: non steroidal; Drug tolerance; Nitric oxide; Opioid; Pain; Protein kinase C; Receptors: N methyl D aspartate (NMDA)

Indexed keywords

G PROTEIN COUPLED RECEPTOR; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OPIATE RECEPTOR; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN KINASE C;

ATTENUATION; DRUG TOLERANCE; FACILITATION; HUMAN; NOCICEPTION; NOCICEPTIVE RECEPTOR; PAIN; RECEPTOR DOWN REGULATION; REVIEW;

ANALGESICS, OPIOID; ANIMALS; DRUG TOLERANCE; HUMANS; NITRIC OXIDE; PAIN; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0034518519     PISSN: 02541319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Acute tolerance associated with a single opiate administration: Involvement of N-methyl-D-aspartate-dependent pain facilitatory systems
2. Acute tolerance in morphine analgesia: Continuous infusion and single injection in rats
3. Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from rat spinal cord slices
4. Acute opiate tolerance in man
5. Morphine-tolerant longitudinal muscle strip from guinea-pig ileum
6. Cellular mechanisms of opioid tolerance: Studies in single brain neurons
7. Cellular and molecular mechanisms of drug dependence
8. Intrathecal pertussis toxin treatment attenuates opioid antinociception and reduces high-affinity state of opioid receptors
9. Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes
10. Opioid agonist binding affinity is increased by magnesium in the presence of guanosine diphosphate but decreased by magnesium in the presence of guanyl-5′-yl imidodiphosphate
11. Reduction of opiate binding to brainstem slices associated with the development of tolerance to morphine in rats
12. Reduction in opiate receptor reserve in morphine tolerant guinea pig ilea
13. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats
14. Morphine-induced opioid receptor down-regulation detected in intact adult rat brain cells
15. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801
16. Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists
17. MK-801 inhibits the development of morphine tolerance at spinal sites
18. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat
19. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat
20. Nitric oxide and opioid tolerance
21. NG-nitro-L-arginine prevents morphine tolerance
22. Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor
23. Comparative effect of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance
24. Intrathecal cyclooxygenase inhibitor administeration attenuates morphine antinociceptive tolerance in rats
25. Poly(ADP-ribose) polymerase: Early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells
26. Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity
27. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions
28. The inhibition of nitric oxide-activated poly (ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat
29. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists
30. Excitatory amino acid receptors and synaptic plasticity
31. Excitatory amino acid regulation of the enkephalin phenotype in mouse embryonic spinal cord cultures
32. The role of neurokinin and N-methyl-D-aspartate receptors in synaptic transmission from capsaicin-sensitive primary afferents in the rat spinal cord in vitro
33. Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord.
34. Excitatory amino acids and synaptic transmission: The evidence for a physiological function
35. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: Binding at mu-opioid receptors
36. The NMDA receptor antagonist MK-801 protects against the development of morphine tolerance after intrathecal administration
37. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: Assessment of opioid receptor changes
38. Blockade of morphine-inducted analgesia and tolerance in mice by MK-801
39. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-asparate receptor antagonist, LY274614
40. 3H] MK-801 binding affinity and constitutive neuronal nitric oxide synthase expression in the rat spinal cord
41. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine
42. The importance of the number of NMDA receptors in the development of supersensitivity of tolerance to and dependence on morphine
43. Epidural coadministration of ketamine, morphine and bupivacaine attenuates post-herpetic neuralgia - A case report
44. Ketamine potentiates analgesic effect of morphine in postoperative epidural pain control
45. Clinical applications of excitatory amino acid antagonists in pain management
46. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?
47. Spinal PKC activity and expression: Role in tolerance produced by continuous spinal morphine infusion
48. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid
49. 2+ block of NMDA-receptor channels as a mechanism of modulation
50. The association of neuropathic pain, morphine tolerance and dependence, and the translocation of protein kinase C
51. The development of morphine tolerance and dependence is associated with translocation of protein kinase C
52. Thermal hyperalgesia in association with the development of morphine tolerance in rats: Roles of excitatory amino acid receptors and protein kinase C.
53. Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions
54. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation
55. Nitric oxide as a secretory product of mammalian cells
56. Nitric oxide: Physiology, pathophysiology, and pharmacology
57. Nitric oxide synthases: Roles, tolls, and controls
58. Nitric oxide (NO) and nociceptive processing in the spinal cord
59. Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse
60. Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat
61. Nitric oxide-mediated spinal disinhibition contributes to the sensitization of primate spinothalamic tract neurons
62. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat
63. Modulation of morphine antinociception in the mouse by endogenous nitric oxide
64. NMDA-dependent prostaglandin E2 release by human cultured astroglial cells in driven by nitric oxide
65. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain
66. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices
67. Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance
68. N-nitro-L-arginine attenuates development of tolerance to antinociceptive but not to hormonal effects of morphine
69. G-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids
70. Kinetic properties of nitric oxide synthase in cerebral cortex and cerebellum of morphine tolerant mice
71. Morphine-induced changes in cerebral and cerebellar nitric oxide synthase activity
72. Chronic morphine increases biosynthesis of nitric oxide synthase in the rat spinal cord
73. Spontaneous expression of inducible nitric oxide synthase in the hypothalamus and other brain regions of aging rats
74. Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain
75. Nitric oxide: A key mediator in the early and late phase of carrageenan-induced rat paw inflammation
76. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat
77. Changes in nitric oxide synthase isoforms in the spinal cord of rat following induction of chronic arthritis
78. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: Evidence for oppossing NO actions on morphine analgesia and tolerance
79. Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal
80. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing
81. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation
82. Aspirin selectively inhibits prostaglandin production in human platelets
83. Epidural nonsteroidal antiinflammatory drugs for cancer pain
84. Intravenous diclofenac coupled with PCA fentanyl for pain relief after total hip replacement
85. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction
86. Ketorolac potentiates morphine antinociception during visceral nociception in the rat
87. Intrathecal ketorolac tromethamine produces analgesia after chronic constriction injury of sciatic nerve in rat
88. Interactions between NMDA- and prostaglandin receptor-mediated events in a model of inflammatory nociception
89. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition
90. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation
91. Nitric oxide activates cyclooxygenase enzymes
92. Stimulation of nitric oxide release from rat spinal cord by prostaglandin E2
93. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase
94. Human cyclooxygenase-2 cDNA
95. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation
96. The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia
97. Prostanoids synthesized by cyclo-oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability